(Q43597205)

25 November 2017

title

Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (English)

1 reference

ESMO Guidelines Working Group

25 November 2017

author

6

object named as

ESMO Guidelines Working Group

1 reference

25 November 2017

4

L Specht

1 reference

25 November 2017

R Willemze

1

1 reference

25 November 2017

E Hodak

2

1 reference

25 November 2017

P L Zinzani

3

1 reference

25 November 2017

M Ladetto

5

1 reference

25 November 2017

publication date

17 July 2013

1 reference

25 November 2017

1 reference

25 November 2017

volume

24 Suppl 6

1 reference

25 November 2017

page(s)

vi149-54

1 reference

WHO-EORTC classification for cutaneous lymphomas

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphoma in Korea: a retrospective study at a single tertiary institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

How I treat mycosis fungoides and Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT242

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT242

1 reference

25 November 2017

1 reference